As ACSH discussed last week, the controversy about the Lipitor Dr. Jarvick advertisements is still heated. ACSH's Dr. Elizabeth Whelan said she was at a party this weekend and a man couldn't believe anyone cared about Dr. Jarvick, developer of the artificial heart, using a body-double in the television ads -- Lipitor, after all, is a fantastic drug.
"The point is not that Lipitor is not a fantastic drug," Dr. Whelan noted. "The point is that the ad unnecessarily introduced a level of fiction with the use of a stand-in actor for Dr. Jarvick's alleged rowing scenes."
As ACSH discussed last week, the controversy about the Lipitor Dr. Jarvick advertisements is still heated. ACSH's Dr. Elizabeth Whelan said she was at a party this weekend and a man couldn't believe anyone cared about Dr. Jarvick, developer of the artificial heart, using a body-double in the television ads -- Lipitor, after all, is a fantastic drug.
"The point is not that Lipitor is not a fantastic drug," Dr. Whelan noted. "The point is that the ad unnecessarily introduced a level of fiction with the use of a stand-in actor for Dr. Jarvick's alleged rowing scenes."
It's frustrating for ACSH staffers because Pfizer made itself so vulnerable with this advertisement -- while there's no crime or FTC violation, it just looks bad.
